Serum Institute puts India trials of AstraZeneca's COVID-19 vaccine on hold after DCGI notice

 Serum Institute of India (SII) has put trials of AstraZeneca’s COVID-19 vaccine candidate on hold until the British drugmaker restarts the trials, Serum said on Thursday. "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following Drug Controller General of India's (DGCI) instructions and will not be able to comment further on trials," Serum said in a brief statement.

from IndiaTV India: Google News Feed https://ift.tt/3bJDIwR
via